Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASH 2020 | Allogeneic hemopoietic stem cell transplants for advanced phase CML

Elena Morozova • 30 Nov 2020
ASH 2020
Chronic Myeloid Leukemia Leukemia

Elena Morozova, MD, PhD, RM Gorbacheva Research Institute, Pavlov University, St. Petersburg, Russian Federation, discusses the clinical need and challenges of performing allogeneic hemopoietic stem cell transplants (allo-HSCT) in patients with advanced phase chronic myeloid leukemia (CML). Dr Morozova goes on to highlight the findings of a comparative study in which patients that received allo-HSCT had significantly improved four-year overall survival (OS) as compared to the non-transplanted group. This interview took place during the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, 2020.

Related Videos

Addressing changes to genomic prognostic markers in CLL beyond the chemotherapy era
4:04
Addressing changes to genomic prognostic markers in CLL beyond the chemotherapy era
Anna Schuh • 16 Oct 2026
Understanding the CLL genome: current knowledge and remaining gaps
3:39
Understanding the CLL genome: current knowledge and remaining gaps
Anna Schuh • 16 Oct 2026
How is frontline fixed-duration acalabrutinib plus venetoclax shaping treatment decisions in CLL?
2:00
How is frontline fixed-duration acalabrutinib plus venetoclax shaping treatment decisions in CLL?
Alexey Danilov • 16 Oct 2026
Autoimmune cytopenias in patients with CLL on venetoclax-based therapy: outcomes from an ERIC study
3:39
Autoimmune cytopenias in patients with CLL on venetoclax-based therapy: outcomes from an ERIC study
Marta Coscia • 16 Oct 2026

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals